Tumor necrosis factor-α, kidney function, and hypertension

American Journal of Physiology - Renal Physiology

Volumn 313, Issue 4, 2017, Pages F1005-F1008

  Mehaffey, Eamonn ^a   Majid, Dewan S A ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Inflammatory cytokines; Natriuresis; Renin angiotensin system; TNF

Indexed keywords

TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; AUTACOID; SALT INTAKE; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2;

HUMAN; HYPERTENSION; KIDNEY FUNCTION; KIDNEY INJURY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; ADVERSE EFFECTS; ANIMAL; BLOOD PRESSURE; IMMUNOLOGY; INFLAMMATION; KIDNEY; METABOLISM; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SALT INTAKE; SIGNAL TRANSDUCTION;

ANIMALS; BLOOD PRESSURE; HUMANS; HYPERTENSION; INFLAMMATION; INFLAMMATION MEDIATORS; KIDNEY; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; RENIN-ANGIOTENSIN SYSTEM; SIGNAL TRANSDUCTION; SODIUM CHLORIDE, DIETARY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 85031295113     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00535.2016     Document Type: Review

References (30)

1. Bourraindeloup M, Adamy C, Candiani G, Cailleret M, Bourin M-C, Badoual T, Su JB, Adubeiro S, Roudot-Thoraval F, Dubois-Rande J-L, Hittinger L, Pecker F. N-acetylcysteine treatment normalizes serum tumor necrosis factor-α level and hinders the progression of cardiac injury in hypertensive rats. Circulation 110: 2003-2009, 2004. doi:10.1161/01.CIR.0000143630.14515.7C.
2. Castillo A, Islam MT, Prieto MC, Majid DS. Tumor necrosis factor-α receptor type 1, not type 2, mediates its acute responses in the kidney. Am J Physiol Renal Physiol 302: F1650-F1657, 2012. doi:10.1152/ajprenal. 00426.2011.
3. Chen CC, Pedraza PL, Hao S, Stier CT, Ferreri NR. TNFR1-deficient mice display altered blood pressure and renal responses to ANG II infusion. Am J Physiol Renal Physiol 299: F1141-F1150, 2010. doi:10. 1152/ajprenal.00344.2010.
4. Elmarakby AA, Quigley JE, Imig JD, Pollock JS, Pollock DM. TNF-α inhibition reduces renal injury in DOCA-salt hypertensive rats. Am J Physiol Regul Integr Comp Physiol 294: R76-R83, 2008. doi:10.1152/ ajpregu.00466.2007.
5. Guzik TJ, Hoch NE, Brown KA, McCann LA, Rahman A, Dikalov S, Goronzy J, Weyand C, Harrison DG. Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J Exp Med 204: 2449-2460, 2007. doi:10.1084/jem.20070657.
6. Huang B, Cheng Y, Usa K, Liu Y, Baker MA, Mattson DL, He Y, Wang N, Liang M. Renal tumor necrosis factor α contributes to hypertension in Dahl salt-sensitive rats. Sci Rep 6: 21960, 2016. doi:10.1038/ srep21960.
7. Bautista LE, Vera LM, Arenas IA, Gamarra G. Independent association between inflammatory markers (C-reactive protein, interleukin-6, and TNF-alpha) and essential hypertension. J Hum Hypertens 19: 149-154, 2005. doi:10.1038/sj.jhh.1001785.
8. Ma S, Zhu XY, Eirin A, Woollard JR, Jordan KL, Tang H, Lerman A, Lerman LO. Perirenal fat promotes renal arterial endothelial dysfunction in obese swine through tumor necrosis factor-α. J Urol 195: 1152-1159, 2016. doi:10.1016/j.juro.2015.08.105.
9. Majid DSA. Tumor necrosis factor-α and kidney function: experimental findings in mice. Adv Exp Med Biol 691: 471-480, 2011. doi:10.1007/ 978-1-4419-6612-4α48.
10. Majid DSA, Kopkan L. Nitric oxide and superoxide interaction in the kidney and its implication in the development of salt-sensitive hypertension. Clin Exp Pharmacol Physiol 34: 946-952, 2007. doi:10.1111/j.1440-1681.2007.04642.x.
11. Majid DSA, Prieto C, Castillo A. -Tumor necrosis factor-alpha receptors (type 1 and type 2) are differentially expressed in renal tissues during chronic dietary intake of high salt and angiotensin II treatment. Hypertension 66: AP247, 2015.
12. Majid DSA, Prieto MC, Navar LG. Salt-sensitive hypertension: perspectives on intrarenal mechanisms. Curr Hypertens Rev 11: 38-48, 2015. doi:10.2174/1573402111666150530203858.
13. Mann DL, McMurray JJ, Packer M, Swedberg K, Borer JS, Colucci WS, Djian J, Drexler H, Feldman A, Kober L, Krum H, Liu P, Nieminen M, Tavazzi L, van Veldhuisen DJ, Waldenstrom A, Warren M, Westheim A, Zannad F, Fleming T. Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL). Circulation 109: 1594-1602, 2004. doi:10.1161/01.CIR.0000124490.27666.B2.
14. Mehaffey EP, Castillo A, Navar LG, Majid D. Intrarenal angiotensinogen production induced by chronic angiotensin II and high salt intake in tumor necrosis factor-alpha receptor type 1 knockout mice (Abstract). FASEB J 30, Suppl 1: 1216.13, 2016.
15. Muller DN, Shagdarsuren E, Park JK, Dechend R, Mervaala E, Hampich F, Fiebeler A, Ju X, Finckenberg P, Theuer J, Viedt C, Kreuzer J, Heidecke H, Haller H, Zenke M, Luft FC. Immunosuppressive treatment protects against angiotensin II-induced renal damage. Am J Pathol 161: 1679-1693, 2002. doi:10.1016/S0002-9440(10)64445-8.
16. Numanami H, Nelson DK, Hoyt JC, Freels JL, Habib M, Amano J, Haniuda M, Koyama S, Robbins RA. Peroxynitrite enhances interleukin-10 reduction in the release of neutrophil chemotactic activity. Am J Respir Cell Mol Biol 29: 239-244, 2003. doi:10.1165/rcmb.2002-0275OC.
17. Rodríguez-Iturbe B, Pons H, Quiroz Y, Johnson RJ. The immunological basis of hypertension. Am J Hypertens 27: 1327-1337, 2014. doi:10. 1093/ajh/hpu142.
18. Schiffrin EL. The immune system: role in hypertension. Can J Cardiol 29: 543-548, 2013. doi:10.1016/j.cjca.2012.06.009.
19. Shahid M, Francis J, Majid DS. Tumor necrosis factor-α induces renal vasoconstriction as well as natriuresis in mice. Am J Physiol Renal Physiol 295: F1836-F1844, 2008. doi:10.1152/ajprenal.90297.2008.
20. Shahid M, Francis J, Matrougui K, Majid DS. Involvement of tumor necrosis factor-α in natriuretic response to systemic infusion of nitric oxide synthase inhibitor in anesthetized mice. Am J Physiol Renal Physiol 299: F217-F224, 2010. doi:10.1152/ajprenal.00611.2009.
21. Singh P, Bahrami L, Castillo A, Majid DS. TNF-α type 2 receptor mediates renal inflammatory response to chronic angiotensin II administration with high salt intake in mice. Am J Physiol Renal Physiol 304: F991-F999, 2013. doi:10.1152/ajprenal.00525.2012.
22. Singh P, Castillo A, Islam MT, Majid DS. Effects of acute systemic inhibition of nitric oxide synthase on plasma levels of pro-and antiinflammatory cytokines in anesthetized mice. FASEB J 26: 1131.14, 2012.
23. Singh P, Castillo A, Majid DS. Decrease in IL-10 and increase in TNF-α levels in renal tissues during systemic inhibition of nitric oxide in anesthetized mice. Physiol Rep 2: e00228, 2014. doi:10.1002/phy2.228.
24. Soon E, Holmes AM, Treacy CM, Doughty NJ, Southgate L, Machado RD, Trembath RC, Jennings S, Barker L, Nicklin P, Walker C, Budd DC, Pepke-Zaba J, Morrell NW. Elevated levels of inflammatory cytokines predict survival in idiopathic and familial pulmonary arterial hypertension. Circulation 122: 920-927, 2010. doi:10.1161/CIRCULATIONAHA.109.933762.
25. Sriramula S, Haque M, Majid DSA, Francis J. Involvement of tumor necrosis factor-alpha in angiotensin II-mediated effects on salt appetite, hypertension, and cardiac hypertrophy. Hypertension 51: 1345-1351, 2008. doi:10.1161/HYPERTENSIONAHA.107.102152.
26. Testa M, Yeh M, Lee P, Fanelli R, Loperfido F, Berman JW, LeJemtel TH. Circulating levels of cytokines and their endogenous modulators in patients with mild to severe congestive heart failure due to coronary artery disease or hypertension. J Am Coll Cardiol 28: 964-971, 1996. doi:10. 1016/S0735-1097(96)00268-9.
27. Therrien FJ, Agharazii M, Lebel M, Larivière R. Neutralization of tumor necrosis factor-alpha reduces renal fibrosis and hypertension in rats with renal failure. Am J Nephrol 36: 151-161, 2012. doi:10.1159/ 000340033.
28. Venegas-Pont M, Manigrasso MB, Grifoni SC, LaMarca BB, Maric C, Racusen LC, Glover PH, Jones AV, Drummond HA, Ryan MJ. Tumor necrosis factor-alpha antagonist etanercept decreases blood pressure and protects the kidney in a mouse model of systemic lupus erythematosus. Hypertension 56: 643-649, 2010. doi:10.1161/HYPERTENSIONAHA.110.157685.
29. Whiting C, Castillo A, Haque MZ, Majid DS. Protective role of the endothelial isoform of nitric oxide synthase in ANG II-induced inflammatory responses in the kidney. Am J Physiol Renal Physiol 305: F1031-F1041, 2013. doi:10.1152/ajprenal.00024.2013.
30. Zhang J, Patel MB, Griffiths R, Mao A, Song YS, Karlovich NS, Sparks MA, Jin H, Wu M, Lin EE, Crowley SD. Tumor necrosis factor-α produced in the kidney contributes to angiotensin II-dependent hypertension. Hypertension 64: 1275-1281, 2014. doi:10.1161/HYPERTENSIONAHA.114.03863.